Sign in
4/A

Changes in Ownership

Eloxx Pharmaceuticals, Inc. Filed Acc 0001415889-20-000637

CHIEF EXECUTIVE OFFICER gave up 2,590 shares (to pay taxes)

  • CHIEF EXECUTIVE OFFICER acquired 7,500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Williams Gregory C. CHIEF EXECUTIVE OFFICER 2020-01-30 Option exercise +7,500 7,500 D: show line 1 in the form
Williams Gregory C. CHIEF EXECUTIVE OFFICER 2020-01-30 Shares withheld for taxes −2,590 $3.91 $10,127 4,910 D: show line 2 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Williams Gregory C. CHIEF EXECUTIVE OFFICER 2020-01-30 Option exercise · Restricted Stock Units −7,500 22,500 D: show line 3 in the form
Loading xslF345X03/form4a-03042020_020307.xml…